The Forkhead Transcription Factor, FOXO1, and its Role in Pituitary Gland Develop
叉头转录因子 FOXO1 及其在脑下垂体发育中的作用
基本信息
- 批准号:7820491
- 负责人:
- 金额:$ 21.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdipocytesAdultAnterior Pituitary HormonesApoptosisBirthBlood VesselsBromodeoxyuridineCandidate Disease GeneCell Differentiation processCell NucleusCell ProliferationCell divisionCellsCongenital AbnormalityCorticotropinDefectDevelopmentEmbryoEndothelial CellsEpitheliumEtiologyFailureFetal ViabilityFoundationsGene ExpressionGenesGeneticGlandGonadal structureHematoxylin and Eosin Staining MethodHormonesHumanHyperplasiaImmunohistochemistryIn Situ Nick-End LabelingKnockout MiceKnowledgeLabelLeadLesionLive BirthMeasuresModelingMorphologyMusMuscleMuscle functionMutationMyoblastsNatureOrganPancreasPatternPhenotypePituitary GlandPituitary HormonesPlayProductionProteinsRoleSpecificityStaining methodStainsTestingThyroid GlandTissuesTranscription factor genesbasecell motilitycell typeembryo tissuefetalforkhead proteinfunctional losshormone deficiencyinhibitor/antagonistmigrationneonatal deathpituitary gland developmentpublic health relevancetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Congenital hormone deficiencies are common, occurring in approximately one in 4,000 live births. Pituitary hormone deficiency can consist of loss of a single hormone (isolated hormone deficiency) or several hormones (combined pituitary hormone deficiency). Absence of anterior pituitary hormones does not interfere with fetal viability, but are required for survival after birth, gonadal differentiation, and maturation of the fetal thyroid. Lesions in the transcription factors PITX1, PITX2, HESX1, LHX3, LHX4, TPIT, PROP1 and PIT1 lead to combined pituitary hormone deficiency in mice and humans. However mutations in these transcription factors account for only a fraction of congenital hormone deficiencies in humans. To identify additional factors that contribute to human congenital hormone deficiencies, we are investigating the forkhead transcription factor, FOXO1, which is important for the normal development of several organs. Mouse knockout models for Foxo1 result in embryonic lethality at embryonic day (e)10.5 due to vascular defects. Our objective is to investigate the contributions of FOXO1 to congenital pituitary hormone deficiency. We hypothesize that eliminating FOXO1 in the pituitary will cause hyperplasia and misorganization of the pituitary gland resulting in loss of hormone production and/or mis-specification of hormone-producing cell types. This hypothesis is based on the following observations. First, our preliminary results show that FOXO1 is present in nuclei of non-dividing pituitary cells starting at e14.5 when these cells are beginning to differentiate. Secondly, FOXO1 inhibits proliferation and regulates differentiation and migration of pancreatic 2-cells, myoblasts, adipocytes, and endothelial cells. To test this hypothesis we propose three specific aims: Specific Aim 1. Determine the pituitary cell specificity for FOXO1 during development. We will perform immunohistochemistry for the hormones that mark the five pituitary cell types in combination with immunohistochemistry for FOXO1 on mouse embryonic tissue at e18.5. Specific Aim 2. Investigate the requirement for Foxo1 in pituitary gland development and function. We will analyze pituitary glands from mouse embryos that have had Foxo1 expression eliminated in the pituitary gland (Foxo1 pit/-). We will assess pituitary morphology, analyze anterior pituitary hormone production, and measure cell proliferation and apoptosis. Specific Aim 3. Place Foxo1 in the genetic hierarchy of pituitary gland developmental control. We will perform immunohistochemistry on Foxo1 pit/- mouse embryos for genes that are required during normal pituitary development. The knowledge generated by these studies will further this field by identifying a candidate gene for congenital pituitary hormone deficiency and by adding to our knowledge of how forkhead factor mutations cause birth defects. Our expertise in both forkhead transcription factor function and pituitary development places us in a unique situation to address this problem.
PUBLIC HEALTH RELEVANCE: Pituitary hormones are essential for survival after birth and for the normal development of gonads and thyroid gland. The forkhead transcription factor, FOXO1, is essential for the normal development and function of muscle, blood vessels, and pancreas. The pattern of FOXO1 localization in the pituitary gland during development suggests a role for inhibiting cell division and regulating cell differentiation. Our objective is to determine the requirement of FOXO1 for normal pituitary development by analyzing the pituitary phenotype in mice that lack FOXO1 in the pituitary gland.
描述(由申请人提供):先天性激素缺乏症很常见,大约每4,000名活产婴儿中就有一名。垂体激素缺乏症可以包括单一激素(孤立性激素缺乏症)或几种激素(联合垂体激素缺乏症)的损失。垂体前叶激素的缺乏不会影响胎儿的生存能力,但对出生后的存活、性腺分化和胎儿甲状腺的成熟是必需的。转录因子PITX 1、PITX 2、HESX 1、LHX 3、LHX 4、TPIT、PROP 1和PIT 1中的病变导致小鼠和人类的垂体激素联合缺乏。然而,这些转录因子的突变仅占人类先天性激素缺乏症的一小部分。为了确定导致人类先天性激素缺乏症的其他因素,我们正在研究叉头转录因子FOXO 1,它对几个器官的正常发育很重要。Foxo 1基因敲除小鼠模型在胚胎第10.5天由于血管缺陷导致胚胎死亡。我们的目的是探讨FOXO 1在先天性垂体激素缺乏症中的作用。我们假设消除垂体中的FOXO 1将导致垂体增生和组织混乱,从而导致激素产生的损失和/或激素产生细胞类型的错误指定。这一假设基于以下观察。首先,我们的初步结果表明,FOXO 1是存在于细胞核的非分裂垂体细胞开始在e14.5时,这些细胞开始分化。其次,FOXO 1抑制胰腺2-细胞、成肌细胞、脂肪细胞和内皮细胞的增殖并调节其分化和迁移。为了验证这一假设,我们提出了三个具体目标:具体目标1。确定发育过程中垂体细胞对FOXO 1的特异性。我们将在e18.5对小鼠胚胎组织进行标记五种垂体细胞类型的激素的免疫组织化学和FOXO 1的免疫组织化学。具体目标2。探讨Foxo 1在垂体发育和功能中的需求。我们将分析来自小鼠胚胎的垂体腺,这些胚胎在垂体腺中消除了Foxo 1表达(Foxo 1 pit/-)。我们将评估垂体形态,分析垂体前叶激素的产生,并测量细胞增殖和凋亡。具体目标3。将Foxo 1置于脑垂体发育控制的遗传层次中。我们将对Foxo 1 pit/-小鼠胚胎进行免疫组化,以确定正常垂体发育过程中所需的基因。这些研究所产生的知识将进一步这一领域确定一个候选基因的先天性垂体激素缺乏症,并通过增加我们的知识叉头因子突变如何导致出生缺陷。我们在叉头转录因子功能和垂体发育方面的专业知识使我们处于解决这个问题的独特位置。
公共卫生相关性:垂体激素对出生后的生存以及性腺和甲状腺的正常发育至关重要。叉头转录因子FOXO 1对肌肉、血管和胰腺的正常发育和功能至关重要。在发育过程中,FOXO 1在脑垂体中的定位模式表明其具有抑制细胞分裂和调节细胞分化的作用。我们的目的是通过分析垂体中缺乏FOXO 1的小鼠的垂体表型来确定FOXO 1对正常垂体发育的需求。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Forkhead Box O1 is present in quiescent pituitary cells during development and is increased in the absence of p27 Kip1.
- DOI:10.1371/journal.pone.0052136
- 发表时间:2012
- 期刊:
- 影响因子:3.7
- 作者:Majumdar S;Farris CL;Kabat BE;Jung DO;Ellsworth BS
- 通讯作者:Ellsworth BS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Buffy Sue Ellsworth其他文献
Buffy Sue Ellsworth的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Buffy Sue Ellsworth', 18)}}的其他基金
Molecular Mechanisms Underlying Somatotrope Differentiation and Function
生长素分化和功能的分子机制
- 批准号:
10359404 - 财政年份:2022
- 资助金额:
$ 21.83万 - 项目类别:
Mechanism by Which FOXO1 Regulates Somatotrope Differentiation and/or Function
FOXO1 调节生长素分化和/或功能的机制
- 批准号:
8626645 - 财政年份:2014
- 资助金额:
$ 21.83万 - 项目类别:
Forkhead Factor, FOXL2, in Pituitary Development
叉头因子 FOXL2 在垂体发育中的作用
- 批准号:
6856547 - 财政年份:2004
- 资助金额:
$ 21.83万 - 项目类别:
Forkhead Factor, FOXL2, in Pituitary Development
叉头因子 FOXL2 在垂体发育中的作用
- 批准号:
6740488 - 财政年份:2004
- 资助金额:
$ 21.83万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 21.83万 - 项目类别:
Research Grant














{{item.name}}会员




